Skip to main content
Clinical Trials/NCT04048096
NCT04048096CompletedNot Applicable

Effects of Krill Oil Supplementation on Muscle Function in Older Adults

University of Glasgow1 site in 1 country102 target enrollmentStarted: March 7, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
102
Locations
1
Primary Endpoint
Change in Muscle strength

Study Overview

Brief Summary

The aim of this study is to determine the effects of krill oil supplementation on muscle mass in function in older adults. Half of the participants will receive krill oil supplements and the other half a placebo.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
65 Years to — (Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •BMI less than 35kg/m2

Exclusion Criteria

  • •severe cardiovascular disease
  • •seizure disorders
  • •uncontrolled hypertension (>150/90mmHg at baseline measurement)
  • •cancer or cancer that has been in remission <5 years
  • •ambulatory impairments which would limit ability to perform assessments of muscle function
  • •taking medication known to affect muscle (e.g. steroids)
  • •have an implanted electronic device (e.g. pacemaker/defibrillator/insulin pump)
  • •on anticoagulant therapy
  • •allergies to seafood
  • •regular consumption of more than 2 portions of oily fish per week.

Arms & Interventions

Placebo

Placebo Comparator

4g/day of mixed vegetable oil supplements

Intervention: Placebo (Dietary Supplement)

Krill

Experimental

4g/day krill oil

Intervention: Krill Oil (Dietary Supplement)

Outcomes

Primary Outcomes

Change in Muscle strength

Time Frame: Change from baseline to 6 months

knee extensor muscle strength

Secondary Outcomes

  • Change in Body Fat(Change from baseline to 6 months)
  • Change in Lean Mass(Change from baseline to 6 months)
  • Change in Grip strength(Change from baseline to 6 months)
  • Change in Fasting glucose(Change from baseline to 6 months)
  • Change in CRP(Change from baseline to 6 months)
  • Change in Muscle thickness(Change from baseline to 6 months)
  • Change in Short performance physical battery test(Change from baseline to 6 months)
  • Change in Blood lipids(Change from baseline to 6 months)
  • Change in Erythrocyte fatty acid profile(Change from baseline to 6 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Stuart Gray

Senior Lecturer in Exercise and Metabolic Health

University of Glasgow

Study Sites (1)

Loading locations...

Similar Trials